Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
Abstract Internal tandem duplication of Fms‐like tyrosine kinase 3 (FLT3/ITD) occurs in about 30% of acute myeloid leukemia (AML) and is associated with poor response to conventional treatment and adverse outcome. Here, we reported that human FLT3/ITD expression led to axis duplication and dorsaliza...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Springer Nature
2020-03-01
|
| 丛编: | EMBO Molecular Medicine |
| 主题: | |
| 在线阅读: | https://doi.org/10.15252/emmm.201910895 |